In pancreatic cancer, the role of mRNA modification at m6A in polo-like kinase 1 in cell cycle homeostasis was demonstrated (27), although the involvement of HuR and 7SL1 was elusive, suggesting that 7SL1 is involved, at least partially, in the process of antagonizing to p53 (Figure 1). This evidence concerns the gene ELAVL1 and pancreatic neoplasm.